Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Doctoral Research Award: Canada Graduate Scholarships

University of Calgary

$105,000.00

Expanding Capacity in Alberta to Deliver Contingency Patient Management in Outpatient Addiction Treatment: A Randomized Clinical Trial for Methamphetamine Use

EF 2020-21

Résumé
Alberta is facing a methamphetamine (MET) crisis. MET-related hospitalizations have increased by 800% between 2010-2015 in Alberta. Promising data indicates that Albertans are increasingly seeking help for their MET use, with treatment enrolments being three times higher in 2018 compared to 2012. Yet, individuals who use MET in Alberta are having significant difficulty remaining in treatment, with a retention rate nearly six times lower than what has been found in other studies with this population. This suggests that the interventions that are currently provided have been ineffective at retaining, and ultimately treating those seeking help for their MET use. Thus, it is important to find a treatment that can improve retention in this population. Contingency management (CM) is an extensively studied treatment for addictions. This intervention provides prizes, like canned goods, when someone meets a behavioural goal, such as attendance. Current findings from the United States have shown that CM improves various outcomes, including retention. Despite research findings, CM is rarely used in Canadian clinical settings. Therefore, this study will implement CM in Alberta (Calgary and Edmonton) for individuals seeking treatment for their MET use. One CM program will incentivize participants for their treatment attendance and the other for MET abstinence. 300 participants will be randomly assigned to one of the CM programs for 12-weeks and a 3, 6, and 12-month follow-up. Prize CM will be used-participants who meet their goal will draw from a prize bowl with a 50% chance of winning. We will evaluate whether CM improves retention, attendance, abstinence, substance use, quality of life, and impacts on the health system. Current efforts to treat MET use in Alberta have been ineffective, leaving this population without the proper care for their addiction. It is hoped the use of CM will increase retention and therefore result in better outcomes in this population.
Programme
Doctoral Research Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
439645
Name
Cowie Megan
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Clinical
Prcname2
Doctoral Research Awards - B
Projecttitle
Expanding Capacity in Alberta to Deliver Contingency Patient Management in Outpatient Addiction Treatment: A Randomized Clinical Trial for Methamphetamine Use
Programtype2
Studentship Programs
Orgnameinp2
University of Calgary
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: Canada Graduate Scholarships
Keyworddelim
Addiction; Contingency Management; Evidence-Based Practices; Methamphetamine; Randomized Controlled Trial
Abstract
Alberta is facing a methamphetamine (MET) crisis. MET-related hospitalizations have increased by 800% between 2010-2015 in Alberta. Promising data indicates that Albertans are increasingly seeking help for their MET use, with treatment enrolments being three times higher in 2018 compared to 2012. Yet, individuals who use MET in Alberta are having significant difficulty remaining in treatment, with a retention rate nearly six times lower than what has been found in other studies with this population. This suggests that the interventions that are currently provided have been ineffective at retaining, and ultimately treating those seeking help for their MET use. Thus, it is important to find a treatment that can improve retention in this population. Contingency management (CM) is an extensively studied treatment for addictions. This intervention provides prizes, like canned goods, when someone meets a behavioural goal, such as attendance. Current findings from the United States have shown that CM improves various outcomes, including retention. Despite research findings, CM is rarely used in Canadian clinical settings. Therefore, this study will implement CM in Alberta (Calgary and Edmonton) for individuals seeking treatment for their MET use. One CM program will incentivize participants for their treatment attendance and the other for MET abstinence. 300 participants will be randomly assigned to one of the CM programs for 12-weeks and a 3, 6, and 12-month follow-up. Prize CM will be used-participants who meet their goal will draw from a prize bowl with a 50% chance of winning. We will evaluate whether CM improves retention, attendance, abstinence, substance use, quality of life, and impacts on the health system. Current efforts to treat MET use in Alberta have been ineffective, leaving this population without the proper care for their addiction. It is hoped the use of CM will increase retention and therefore result in better outcomes in this population.
Competitiondate
202011
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Cowie, Megan
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~